dc.contributor.author | Bea Mascato, Brais | |
dc.contributor.author | Neira Goyanes, Elena | |
dc.contributor.author | Iglesias Rodríguez, Antía | |
dc.contributor.author | Valverde Pérez, Diana | |
dc.date.accessioned | 2023-02-02T12:49:40Z | |
dc.date.available | 2023-02-02T12:49:40Z | |
dc.date.issued | 2022-10-13 | |
dc.identifier.citation | Frontiers in Molecular Biosciences, 9, 9:992313 (2022) | spa |
dc.identifier.issn | 2296889X | |
dc.identifier.uri | http://hdl.handle.net/11093/4411 | |
dc.description.abstract | Background: ALMS1 is a ubiquitous gene associated with Alström syndrome
(ALMS). The main symptoms of ALMS affect multiple organs and tissues,
generating at last, multi-organic fibrosis in the lungs, kidneys and liver. TGF-
β is one of the main pathways implicated in fibrosis, controlling the cell cycle,
apoptosis, cell migration, cell adhesion and epithelial-mesenchymal transition
(EMT). Nevertheless, the role of ALMS1 gene in fibrosis generation and other
implicated processes such as cell migration or cell adhesion via the TGF- β
pathway has not been elucidated yet.
Methods: Initially, we evaluated how depletion of ALMS1 affects different
processes like apoptosis, cell cycle and mitochondrial activity in HeLa cells.
Then, we performed proteomic profiling with TGF-β stimuli in HeLa ALMS1 −/−
cells and validated the results by examining different EMT biomarkers using
qPCR. The expression of these EMT biomarkers were also studied in hTERT-BJ-
5ta ALMS1 −/−. Finally, we evaluated the SMAD3 and SMAD2 phosphorylation
and cell migration capacity in both models.
Results: Depletion of ALMS1 generated apoptosis resistance to thapsigargin
(THAP) and C2-Ceramide (C2-C), and G2/M cell cycle arrest in HeLa cells. For
mitochondrial activity, results did not show significant differences between
ALMS1 +/+ and ALMS1 −/−. Proteomic results showed inhibition of downstream
pathways regulated by TGF-β. The protein-coding genes (PCG) were associated
with processes like focal adhesion or cell-substrate adherens junction in HeLa.
SNAI1 showed an opposite pattern to what would be expected when activating
the EMT in HeLa and BJ-5ta. Finally, in BJ-5ta model a reduced activation of
SMAD3 but not SMAD2 were also observed. In HeLa model no alterations in the
canonical TGF-β pathway were observed but both cell lines showed a reduction
in migration capacity.
Conclusion: ALMS1 has a role in controlling the cell cycle and the apoptosis
processes. Moreover, the depletion of ALMS1 affects the signal transduction
through the TGF-β and other processes like the cell migration and adhesion
capacity. | en |
dc.description.sponsorship | Ministerio de Educación, Cultura y Deporte | Ref. FPU17/01567 | spa |
dc.description.sponsorship | Instituto de Salud Carlos III | Ref. PI15/00049 | spa |
dc.description.sponsorship | Instituto de Salud Carlos III | Ref. PI19/00332 | spa |
dc.description.sponsorship | Xunta de Galicia | Ref. ED431G-2019/06 | spa |
dc.description.sponsorship | Xunta de Galicia | Ref. ED431C-2018/54 | spa |
dc.language.iso | eng | spa |
dc.publisher | Frontiers in Molecular Biosciences | spa |
dc.relation | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI19/00332/ES | |
dc.relation | info:eu-repo/grantAgreement/MINECO/PI15/00049/ES | |
dc.relation | info:eu-repo/grantAgreement/MIU//FPU 17/01567/ES | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Depletion of ALMS1 affects TGF-β signalling pathway and downstream processes such as cell migration and adhesion capacity | en |
dc.type | article | spa |
dc.rights.accessRights | openAccess | spa |
dc.identifier.doi | 10.3389/fmolb.2022.992313 | |
dc.identifier.editor | https://www.frontiersin.org/articles/10.3389/fmolb.2022.992313/full | spa |
dc.publisher.departamento | Bioquímica, xenética e inmunoloxía | spa |
dc.publisher.grupoinvestigacion | Xenómica e Biomedicina | spa |
dc.subject.unesco | 2410.07 Genética Humana | spa |
dc.subject.unesco | 3201.02 Genética Clínica | spa |
dc.subject.unesco | 2407.02 Citogenética | spa |
dc.date.updated | 2023-02-02T12:45:55Z | |
dc.computerCitation | pub_title=Frontiers in Molecular Biosciences|volume=9|journal_number=|start_pag=9:992313|end_pag= | spa |